Advertisement

OTRK

Ontrak, Inc.

Healthcare · USD

Set alert

Price alert · OTRK

All alert types
0.33 USD 0.00 0.00%
As of Mar 9, 2026
0.3299 Day range 0.3299

52-week range unavailable

YTD
+329,800.00%
1 year
+329,800.00%
Open
0.3299
Prev close
0.3299
Mkt cap
6.03M
Vol
258.32K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.3299
High
0.3299
Forward P/E
-0.34
Beta
2.60
Short ratio
0.01
Inst. own
0.21%
Dividend
0.00
Ex-div date
50-d avg
1.84
200-d avg
3.31
1y target
4.00

2Y chart

Chart tools
Interval
OTRK two-year price chart0.004.018.0312.016.1Feb 24Jun 24Oct 24Mar 25Jul 25Feb 26

Key statistics

Market cap
6.03M
Enterprise value
5.57M
Trailing P/E
0.04
Forward P/E
-0.34
PEG ratio
0.00
Price / sales
0.49
Price / book
0.26
EPS (TTM)
31.91
Beta
2.60
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-222.54%
Revenue (TTM)
12.38M
Revenue growth
-17.20%
Free cash flow
-13.42M
Total cash
7.29M
Total debt
7.17M
Return on equity
-340.91%
Shares outstanding
4.22M
Short % of float
2.73%
50-day average
1.84
200-day average
3.31

Analyst view

Consensus: none

Price target (mean) 4.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
OTRK Revenue — quarterly 2.02M
2021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 2025
OTRK Net income — quarterly -6.89M
2021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 2025
OTRK EPS — quarterly -1.65
2021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 2025

Earnings

OTRK recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 13, 2024Sep 1, 2024-1.56-1.77-0.21-13.46%
Aug 8, 2024Jun 1, 2024-1.50-2.85-1.35-90.00%
May 14, 2024Mar 1, 2024-2.85-1.65+1.20+42.11%
Apr 16, 2024Dec 1, 20230.00-4.35——
Nov 14, 2023Sep 1, 20230.00-24.14——
Aug 9, 2023Jun 1, 20230.00-24.89——

Upgrades / downgrades

OTRK analyst upgrades and downgrades
DateFirmActionFromTo
Aug 9, 2024Roth MKMmainBuyBuy
Dec 5, 2023Roth MKMinit—Buy

About Ontrak, Inc.

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on OTRK — it syncs with the Stock Master app.

Insider holders

OTRK insider holders
InsiderRelationLatest transactionDateShares held
FELD JUDITHOfficerConversion of Exercise of derivative securityJun 13, 2023578
GORLIN STEVENDirectorPurchaseJun 14, 20180
HILL ARIKChief Technology OfficerPurchaseMay 23, 202251,673
LAVERNE BRANDON HChief Operating OfficerStock Award(Grant)Aug 29, 202228,960
MEDEIROS CURTISChief Operating OfficerPurchaseMar 22, 202065,821
OSBORNE MARY LOUISEOfficerStock Award(Grant)Aug 31, 202220,000

Institution ownership

OTRK institution ownership
Holder% heldSharesValueReported
UBS Group AG0.04%1,6302.33KSep 29, 2024
Blackrock Inc.0.03%1,0571.51KSep 29, 2024
Tower Research Capital LLC (TRC)0.01%239341Sep 29, 2024
Morgan Stanley0.01%473676Sep 29, 2024
Pfs Partners, LLC 0.00%138197Sep 29, 2024
JP Morgan Chase & Company0.00%5680Sep 29, 2024

Fund ownership

OTRK fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.15%6,3129.03KOct 30, 2024
Fidelity Series Total Market Index Fund0.04%1,5362.20KOct 30, 2024
Vanguard Extended Market Index Fund0.03%1,3551.94KSep 29, 2024
Guggenheim Active Allocation Fund0.00%11Aug 30, 2024
Fidelity Total Market Index Fund0.00%130185Oct 30, 2024
Advertisement